Glutamate: The Master Neurotransmitter and Its Implications in Chronic Stress and Mood Disorders

被引:69
|
作者
Pal, Mia Michaela [1 ]
机构
[1] In Cognit UK, Church Lawton, England
来源
FRONTIERS IN HUMAN NEUROSCIENCE | 2021年 / 15卷
关键词
glutamate; neuroplasticity; GABA; NMDA-receptor; long-term potentiation; MAGNETIC-RESONANCE-SPECTROSCOPY; LONG-TERM POTENTIATION; PARTIAL AGONIST; KETAMINE; DEPRESSION; METAANALYSIS; INHIBITION; MODULATION; MECHANISMS; GLYX-13;
D O I
10.3389/fnhum.2021.722323
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This brief review article makes the argument that glutamate is deserving of its newfound attention within the neuroscience literature and that many directions of important research have yet to be explored. Glutamate is an excitatory neurotransmitter with several types of receptors found throughout the central nervous system, and its metabolism is important to maintaining optimal levels within the extracellular space. As such, it is important to memory, cognition, and mood regulation. The mechanisms by which chronic stress affect the glutamatergic system and neuroplasticity are outlined. Several implications for potential pharmacologic and non-pharmacologic interventions are discussed.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
    Sanacora, Gerard
    Treccani, Giulia
    Popoli, Maurizio
    NEUROPHARMACOLOGY, 2012, 62 (01) : 63 - 77
  • [2] Glutamate and GABA contributions to medial prefrontal cortical activity to emotion: Implications for mood disorders
    Stan, Ana D.
    Schirda, Claudiu V.
    Bertocci, Michele A.
    Bebko, Genna M.
    Kronhaus, Dina M.
    Aslam, Haris A.
    LaBarbara, Eduard J.
    Tanase, Costin
    Lockovich, Jeanette C.
    Pollock, Myrna H.
    Stiffler, Richelle S.
    Phillips, Mary L.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2014, 223 (03) : 253 - 260
  • [3] GABA and glutamate systems as therapeutic targets in depression and mood disorders
    Kendell, SF
    Krystal, JH
    Sanacora, G
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (01) : 153 - 168
  • [4] Therapeutic implications for NMDA receptors in mood disorders
    Hashimoto, Kenji
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (07) : 735 - 737
  • [5] The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
    Peterlik, Daniel
    Flor, Peter J.
    Uschold-Schmidt, Nicole
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (05) : 514 - 539
  • [6] Effective Mechanism for Synthesis of Neurotransmitter Glutamate and its Loading into Synaptic Vesicles
    Takeda, Kouji
    Ueda, Tetsufumi
    NEUROCHEMICAL RESEARCH, 2017, 42 (01) : 64 - 76
  • [7] Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
    Haroon, Ebrahim
    Miller, Andrew H.
    Sanacora, Gerard
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (01) : 193 - 215
  • [8] Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
    Yuksel, Cagri
    Oenguer, Dost
    BIOLOGICAL PSYCHIATRY, 2010, 68 (09) : 785 - 794
  • [9] Pramipexole, a D3 receptor agonist, increases cortical gamma power and biochemical correlates of cortical excitation; implications for mood disorders
    Gilbert, Karli F.
    Amontree, Matthew
    Deasy, Samantha
    Ma, Junfeng
    Conant, Katherine
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 60 (10) : 6490 - 6508
  • [10] Mood disorders: Regulation by metabotropic glutamate receptors
    Pilc, Andrzej
    Chaki, Shigeyuki
    Nowak, Gabriel
    Witkin, Jeffrey M.
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (05) : 997 - 1006